| 摘要 |
<p>A compound according to formula I: or a pharmaceutically acceptable salt thereof; wherein R1, R2, R3a, R3b, R3c and R3d are as defined in the specification, pharmaceutical compositions thereof, and methods of use thereof.</p> |
| 申请人 |
EXELIXIS, INC.;BROWN, S., DAVID;DU, HONGWANG;FRANZINI, MAURIZIO;GALAN, ADAM, ANTONI;HUANG, PING;KEARNEY, PATRICK;KIM, MOON, HWAN;KOLTUN, ELENA, S.;RICHARDS, STEVEN, JAMES;TSUHAKO, AMY, L.;ZAHARIA, CRISTIANA, A. |
发明人 |
BROWN, S., DAVID;DU, HONGWANG;FRANZINI, MAURIZIO;GALAN, ADAM, ANTONI;HUANG, PING;KEARNEY, PATRICK;KIM, MOON, HWAN;KOLTUN, ELENA, S.;RICHARDS, STEVEN, JAMES;TSUHAKO, AMY, L.;ZAHARIA, CRISTIANA, A. |
